Amphastar PharmaceuticalsvsJohnson & Johnson

AMPH and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

AMPH

Amphastar Pharmaceuticals, Inc.

$29.17

Value $1.2B

-0.68%
AMPH's page

Amphastar Pharmaceuticals (AMPH) has a market value of $1.2B and Johnson & Johnson (JNJ) $681B. Over the last year, with dividends, AMPH moved +11.9% and JNJ +47.5%. The P/E is 12.6 for AMPH and 42.3 for JNJ. Dividend yield: AMPH none, JNJ 1.87%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMPH$1.2B

    JNJ$681B

    JNJ is 547 times AMPH

  • Revenue, 12 months

    AMPH$746M

    JNJ$99.3B

    JNJ is 133 times AMPH

  • Net income, 12 months

    AMPH$99M

    JNJ$16.1B

    JNJ is 163 times AMPH

  • Operating margin

    AMPH18.7%

    JNJ–

  • ROIC

    AMPH7.6%

    JNJ12.4%

    4.7 points apart

  • P/E

    AMPH12.6

    JNJ42.3

    JNJ is 3.4 times AMPH

  • Dividend yield

    AMPH0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    AMPH+37.9%

    JNJ+98.6%

    60.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMPH+37.9%

JNJ+98.6%

10020030020222023202420252026
Returns by period
PeriodAMPHWith dividendsJNJWith dividends
1 year since November 14, 2025+11.9%Price +11.9%+47.5%Price +44.2%
3 years since November 16, 2023-48.1%-19.6% a yearPrice -48.1%+105.0%+27.0% a yearPrice +88.2%
5 years since November 15, 2021+37.9%+6.6% a yearPrice +37.9%+98.6%+14.7% a yearPrice +72.8%
10 years since November 16, 2016+37.4%+3.2% a yearPrice +37.4%+218.6%+12.3% a yearPrice +142.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMPHAmphastar PharmaceuticalsJNJJohnson & Johnson

Valuation

AMPHJNJ
Valuation
Price$29.17$282.55
Market value$1.2B$681B
Enterprise value (EV)$1.6B$708B
P/E12.642.3
P/E, 5-year median16.121.9
P/B1.58.4
EV/EBIT11.639.9
Free cash flow yield11.2%3.0%

Results and growth

AMPHJNJ
Results and growth
Revenue, 12 months$746M$99.3B
Net income, 12 months$99M$16.1B
Free cash flow, 12 months$139M$20.6B
Earnings per share, 12 months$2.19$6.59
Revenue growth, year on year-1.7%6.1%
Revenue growth a year, past+15.5%over 5 years+2.7%over 5 years
EPS growth a year, past+132.3%over 5 years+14.9%over 5 years

Margins and returns on capital

AMPHJNJ
Margins and returns on capital
Gross margin46.8%67.6%
Operating margin18.7%–
Net margin13.3%16.2%
ROIC7.6%12.4%
ROE12.6%19.7%

Balance sheet

AMPHJNJ
Balance sheet
Cash$231M$17.2B
Total debt$692M$44.7B
Net debt / EBITDA2.21.1
Interest cover5.3×18.0×

Dividends and buybacks

AMPHJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield6.1%0.9%
Shareholder yield6.1%2.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMPH or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Amphastar Pharmaceuticals or Johnson & Johnson?

By market value, Johnson & Johnson ($681B) is about 547.3 times Amphastar Pharmaceuticals ($1.2B), at today's prices.

How did AMPH and JNJ stock do over the last 10 years?

Since November 16, 2016, AMPH's price moved +37.4% and JNJ's +142.8%. With dividends: AMPH +37.4% (+3.2% a year), JNJ +218.6% (+12.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMPH or JNJ?

The dividend yield at today's price is none for Amphastar Pharmaceuticals and 1.87% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of AMPH and JNJ?

At today's price, the P/E is 12.6 for AMPH and 42.3 for JNJ. The median of the last five years was 16.1 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Amphastar Pharmaceuticals or Johnson & Johnson?

Over the last twelve months, the net margin was 13.3% for Amphastar Pharmaceuticals and 16.2% for Johnson & Johnson, and the operating margin 18.7% and –. Revenue was $746M and $99.3B.

Which is the better investment, Amphastar Pharmaceuticals or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.